10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2020-05-15 (Q1 2020) | Holdings: 48 | Value: $3.2B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A S | Add 17% ($82.2M) | 17.48% | $553.5M | +24.00% | +3.56% | -5.27% | |
| RARX - RA PHARMACEUTICALS INC | 7.37% | $233.2M | |||||
| CCXI - CHEMOCENTRYX INC | Add 31% ($39.3M) | 5.30% | $167.8M | +5.88% | -79.94% | ||
| ARVN - ARVINAS INC | 4.68% | $148.0M | -85.17% | -41.44% | +44.14% | ||
| ZGNX - ZOGENIX INC | Add 133% ($74.6M) | 4.12% | $130.5M | -11.44% | -33.09% | ||
| AXSM - AXSOME THERAPEUTICS INC | Add 418% ($90.4M) | 3.54% | $112.0M | +25.46% | -7.52% | -33.15% | |
| EIDX - EIDOS THERAPEUTICS INC | 3.35% | $105.9M | +1.13% | ||||
| TGTX - TG THERAPEUTICS INC | Add 5% ($5.0M) | 3.23% | $102.2M | +94.55% | +12.72% | +67.57% | |
| STSA - SATSUMA PHARMACEUTICALS INC | 3.18% | $100.8M | +6.37% | -79.10% | |||
| ALEC - ALECTOR INC | Add 313% ($75.5M) | 3.15% | $99.6M | -95.07% | -50.89% | -38.93% | |
| PHAT - PHATHOM PHARMACEUTICALS INC | Add 2% ($1.6M) | 3.02% | $95.7M | -88.25% | -0.63% | -16.13% | |
| KALA - KALA PHARMACEUTICALS INC | Add 140% ($55.7M) | 3.02% | $95.6M | -99.32% | -23.96% | -56.09% | |
| RYTM - RHYTHM PHARMACEUTICALS INC | 2.61% | $82.5M | +246.13% | -3.50% | +17.13% | ||
| ETNB - 89BIO INC | 2.52% | $79.8M | -64.61% | +12.83% | -22.71% | ||
| EXEL - EXELIXIS INC | New Purchase | 2.46% | $77.9M | +61.16% | -13.62% | -3.99% | |
| WVE - WAVE LIFE SCIENCES LTD | 2.30% | $72.9M | -37.38% | -15.49% | -42.49% | ||
| ADVM - ADVERUM BIOTECHNOLOGIES INC | New Purchase | 2.24% | $71.1M | -98.74% | -28.68% | -81.36% | |
| MNTA - MOMENTA PHARMACEUTICALS INC | Add 75% ($29.5M) | 2.18% | $68.9M | -9.48% | |||
| BDTX - BLACK DIAMOND THERAPEUTICS INC | New Purchase | 2.04% | $64.6M | -94.17% | -29.98% | -41.35% | |
| TVTX - RETROPHIN INC | Reduce 2% $(1.3M) | 1.92% | $60.8M | -9.36% | +16.07% | +14.22% | |
| ORTX - ORCHARD THERAPEUTICS PLC | Add 62% ($21.9M) | 1.80% | $57.0M | -51.69% | -44.21% | ||
| IGMS - IGM BIOSCIENCES INC | 1.74% | $55.2M | -98.00% | -15.81% | +10.05% | ||
| VSTM - VERASTEM INC | New Purchase | 1.55% | $49.1M | -71.07% | -17.42% | +65.17% | |
| RLMD - RELMADA THERAPEUTICS INC | Add 81% ($21.1M) | 1.49% | $47.1M | -98.23% | -15.85% | -24.64% | |
| GILD - GILEAD SCIENCES INC | New Purchase | 1.29% | $41.0M | +76.80% | -8.76% | -5.80% | |
| PRVL - PREVAIL THERAPEUTICS INC | Reduce 4% $(1.5M) | 1.25% | $39.5M | -14.87% | |||
| ARDX - ARDELYX INC | Add 20% ($6.0M) | 1.15% | $36.5M | -52.11% | -22.30% | -10.13% | |
| ARQT - ARCUTIS BIOTHERAPEUTICS INC | New Purchase | 1.10% | $34.7M | -48.22% | +0.50% | -3.87% | |
| ADAP - ADAPTIMMUNE THERAPEUTICS PLC | New Purchase | 1.08% | $34.1M | -94.19% | +79.67% | +0.20% | |
| CRNX - CRINETICS PHARMACEUTICALS INC | Add 5% ($1.3M) | 0.91% | $28.8M | +56.14% | -23.19% | -19.57% | |
| SCPH - SCPHARMACEUTICALS INC | Add 8% ($2.0M) | 0.82% | $26.0M | -62.60% | -24.84% | -46.50% | |
| TRIL - TRILLIUM THERAPEUTICS INC | New Purchase | 0.81% | $25.7M | +54.62% | +44.88% | ||
| STOK - STOKE THERAPEUTICS INC | 0.81% | $25.6M | -58.36% | +9.87% | +34.67% | ||
| IMRA - IMARA INC | New Purchase | 0.74% | $23.3M | ||||
| CGEN - COMPUGEN LTD | New Purchase | 0.68% | $21.5M | -86.73% | +39.64% | -38.87% | |
| IMGN - IMMUNOGEN INC | New Purchase | 0.56% | $17.6M | -18.72% | +47.80% | ||
| NVCR - NOVOCURE LTD | New Purchase | 0.55% | $17.4M | -75.13% | +15.80% | +164.55% | |
| CNCE - CONCERT PHARMACEUTICALS INC | New Purchase | 0.52% | $16.4M | +18.91% | -54.10% | ||
| SLDB - SOLID BIOSCIENCES INC | 0.35% | $10.9M | -90.49% | -10.07% | +19.13% | ||
| GRTX - GALERA THERAPEUTICS INC | Reduce 15% $(1.5M) | 0.27% | $8.5M | -99.79% | -31.34% | -30.99% | |
| XFOR - X4 PHARMACEUTICALS INC | Add 123% ($3.3M) | 0.19% | $6.0M | -98.66% | -0.33% | -18.41% | |
| PASG - PASSAGE BIO INC | New Purchase | 0.16% | $5.1M | -97.94% | -31.44% | -32.27% | |
| QURE - UNIQURE NV | New Purchase | 0.12% | $3.9M | -72.15% | -31.01% | -46.84% | |
| EPIX - ESSA PHARMA INC | Reduce 4% $(162.8K) | 0.12% | $3.8M | -63.23% | +44.09% | +532.26% | |
| PTLA - PORTOLA PHARMACEUTICALS INC | 0.10% | $3.1M | |||||
| SELB - SELECTA BIOSCIENCES INC | New Purchase | 0.07% | $2.1M | ||||
| INSM - INSMED INC | New Purchase | 0.04% | $1.4M | +179.77% | +6.96% | +0.15% | |
| VCEL - VERICEL CORP | New Purchase | 0.03% | $917.0K | +181.82% | +4.48% | +231.30% | |
| BOLD - AUDENTES THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| DVAX - DYNAVAX TECHNOLOGIES CORP | Reduce 100% | 0.00% | $0.00 | ||||
| FTSV - FORTY SEVEN INC | Reduce 100% | 0.00% | $0.00 | ||||
| THOR - SYNTHORX INC | Reduce 100% | 0.00% | $0.00 | ||||